SCHEMBL14449263

SCHEMBL14449263

CCOC(=O)COc1ccc(SCCCc2sc3ccc(C(F)(F)F)cc3c2C)cc1C

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 19/20 0.45
PPARA Q07869 3/20 0.45
PPARG P37231 2/20 0.45
ESR1 P03372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14017062 0.92 PPARD (0.41) PPARDPPARAPPARGESR1
SCHEMBL4655286 0.91 PPARD (0.55) PPARDPPARAPPARG
SCHEMBL14449262 0.87 PPARD (0.39) PPARDPPARAPPARGESR1
SCHEMBL14016243 0.87 PPARD (0.42) PPARDPPARAPPARGESR1
SCHEMBL14449268 0.86 PPARD (0.41) PPARDPPARAPPARGESR1
SCHEMBL14449269 0.86 PPARD (0.37) PPARDPPARAPPARGESR1
SCHEMBL4654136 0.84 PPARD (0.47) PPARDPPARAPPARG
SCHEMBL1034264 0.83 ESR1 (0.43) PPARDPPARAPPARGESR1
SCHEMBL14449274 0.82 PPARD (0.46) PPARDPPARAPPARGESR1
SCHEMBL14449265 0.82 PPARD (0.44) PPARDPPARAPPARGESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease ABAT, BPTF, TNNT2 PPARD 47/4885PPARA 115/4885PPARG 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.